These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 30148088)
21. Association of Functional Polymorphism in Protein Tyrosine Phosphatase Nonreceptor 22 (PTPN22) Gene with Vitiligo. Huraib GB; Al Harthi F; Arfin M; Aljamal A; Alrawi AS; Al-Asmari A Biomark Insights; 2020; 15():1177271920903038. PubMed ID: 32076368 [TBL] [Abstract][Full Text] [Related]
22. Influence of the TSH receptor gene on susceptibility to Graves' disease and Graves' ophthalmopathy. Yin X; Latif R; Bahn R; Tomer Y; Davies TF Thyroid; 2008 Nov; 18(11):1201-6. PubMed ID: 18925838 [TBL] [Abstract][Full Text] [Related]
23. Distribution of PTPN22 polymorphisms in SLE from western Mexico: correlation with mRNA expression and disease activity. Machado-Contreras JR; Muñoz-Valle JF; Cruz A; Salazar-Camarena DC; Marín-Rosales M; Palafox-Sánchez CA Clin Exp Med; 2016 Aug; 16(3):399-406. PubMed ID: 26013387 [TBL] [Abstract][Full Text] [Related]
24. The +1858C/T PTPN22 gene polymorphism confers genetic susceptibility to rheumatoid arthritis in Mexican population from the Western Mexico. Torres-Carrillo NM; Ruiz-Noa Y; Martínez-Bonilla GE; Leyva-Torres SD; Torres-Carrillo N; Palafox-Sánchez CA; Navarro-Hernández RE; Rangel-Villalobos H; Oregón-Romero E; Muñoz-Valle JF Immunol Lett; 2012 Sep; 147(1-2):41-6. PubMed ID: 22743847 [TBL] [Abstract][Full Text] [Related]
26. Use of Tag single nucleotide polymorphisms (SNPs) to screen PTPN21: no association with Graves' disease. Zeitlin AA; Heward JM; Brand OJ; Newby PR; Franklyn JA; Gough SC; Simmonds MJ Clin Endocrinol (Oxf); 2006 Sep; 65(3):380-4. PubMed ID: 16918960 [TBL] [Abstract][Full Text] [Related]
27. Methylation levels of the TNFA gene are different between Graves' and Hashimoto's diseases and influenced by the TNFA polymorphism. Morita E; Watanabe M; Inoue N; Hashimoto H; Haga E; Hidaka Y; Iwatani Y Autoimmunity; 2018 May; 51(3):118-125. PubMed ID: 29526119 [TBL] [Abstract][Full Text] [Related]
28. Association of the PTPN22 R620W polymorphism with anti-topoisomerase I- and anticentromere antibody-positive systemic sclerosis. Gourh P; Tan FK; Assassi S; Ahn CW; McNearney TA; Fischbach M; Arnett FC; Mayes MD Arthritis Rheum; 2006 Dec; 54(12):3945-53. PubMed ID: 17133608 [TBL] [Abstract][Full Text] [Related]
29. CTLA4 gene and Graves' disease: association of Graves' disease with the CTLA4 exon 1 and intron 1 polymorphisms, but not with the promoter polymorphism. Vaidya B; Oakes EJ; Imrie H; Dickinson AJ; Perros P; Kendall-Taylor P; Pearce SH Clin Endocrinol (Oxf); 2003 Jun; 58(6):732-5. PubMed ID: 12780750 [TBL] [Abstract][Full Text] [Related]
30. Protein tyrosine phosphatase non-receptor type 22 (PTPN22) +1858 C>T gene polymorphism in Egyptian cases with rheumatoid arthritis. Salama A; Elshazli R; Elsaid A; Settin A Cell Immunol; 2014 Jul; 290(1):62-5. PubMed ID: 24880676 [TBL] [Abstract][Full Text] [Related]
31. DNA hypermethylation of PTPN22 gene promoter in children and adolescents with Hashimoto thyroiditis. Kyrgios I; Giza S; Fragou A; Tzimagiorgis G; Galli-Tsinopoulou A J Endocrinol Invest; 2021 Oct; 44(10):2131-2138. PubMed ID: 33751486 [TBL] [Abstract][Full Text] [Related]
32. The role of PTPN22 gene polymorphism in childhood immune thrombocytopenic purpura. Anis SK; Abdel Ghany EA; Mostafa NO; Ali AA Blood Coagul Fibrinolysis; 2011 Sep; 22(6):521-5. PubMed ID: 21597364 [TBL] [Abstract][Full Text] [Related]
33. 1858 C/T polymorphism of the protein tyrosine phosphatase nonreceptor 22 gene and rheumatoid arthritis risk in europeans: a meta-analysis. Nong LM; Ren KW; Xu NW; Zhou D Arch Med Res; 2011 Nov; 42(8):698-702. PubMed ID: 22209972 [TBL] [Abstract][Full Text] [Related]
34. PTPN22 C1858T polymorphism in women with endometriosis. Gomes FM; Bianco B; Teles JS; Christofolini DM; de Souza AM; Guedes AD; Barbosa CP Am J Reprod Immunol; 2010 Mar; 63(3):227-32. PubMed ID: 20070289 [TBL] [Abstract][Full Text] [Related]
35. Tumor necrosis factor receptor II and PTPN22 genes polymorphisms and the risk of systemic lupus erythematosus in Egyptian children. Eid R; Hammad A; Abdelsalam M; Fathy AA; Abd-El Ghafaar DM; Elmarghany EB; El-Hanafy AA; Mostafa N; Niazey NA; Korkor MS; Hamdy N Lupus; 2021 Aug; 30(9):1449-1458. PubMed ID: 34080911 [TBL] [Abstract][Full Text] [Related]
36. Associations of single nucleotide polymorphisms of PTPN22 and Ctla4 genes with the risk of allergic rhinitis in a Chinese Han population. Ke X; Song S; Wang X; Shen Y; Kang H; Hong S Hum Immunol; 2017 Feb; 78(2):227-231. PubMed ID: 27888068 [TBL] [Abstract][Full Text] [Related]
37. Association between PTPN22 C1858T polymorphism and alopecia areata risk. Salinas-Santander M; Sánchez-Domínguez C; Cantú-Salinas C; Gonzalez-Cárdenas H; Cepeda-Nieto AC; Cerda-Flores RM; Ortiz-López R; Ocampo-Candiani J Exp Ther Med; 2015 Nov; 10(5):1953-1958. PubMed ID: 26640579 [TBL] [Abstract][Full Text] [Related]
38. Relation of three polymorphisms of the CTLA-4 gene in patients with Graves' disease. Kouki T; Gardine CA; Yanagawa T; Degroot LJ J Endocrinol Invest; 2002 Mar; 25(3):208-13. PubMed ID: 11936461 [TBL] [Abstract][Full Text] [Related]
39. The PTPN22 C1858T functional polymorphism and autoimmune diseases--a meta-analysis. Lee YH; Rho YH; Choi SJ; Ji JD; Song GG; Nath SK; Harley JB Rheumatology (Oxford); 2007 Jan; 46(1):49-56. PubMed ID: 16760194 [TBL] [Abstract][Full Text] [Related]
40. Role of C1858T Polymorphism of Lymphoid Tyrosine Phosphatase in Egyptian Children and Adolescents with Type 1 Diabetes. El Fotoh WMMA; El Razek Midan DA; El Shalakany AH Curr Diabetes Rev; 2019; 16(1):73-79. PubMed ID: 29984661 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]